Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

With Apps & Remote Medicine, Japan Offers Glimpse of Doctor Visits in Post-COVID-19 Era

Kaori Kaneko & Izumi Nakagawa  |  July 13, 2020

TOKYO (Reuters)—The coronavirus crisis has prompted Japan to ease regulations on remote medical treatment, creating an opening for tech companies and offering a glimpse of the future of healthcare in the world’s most rapidly aging society.

As coronavirus cases spiked in April, Japan temporarily eased restrictions on remote medical care, allowing doctors to conduct first-time visits online or by telephone and expanding the number of illnesses that can be treated remotely.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The changes mark a potential shake-up in one of the world’s biggest medical markets, which has lagged countries like Australia, China and the U.S. in telemedicine. The reforms could also help Japan grapple with both a skyrocketing healthcare burden and few doctors in rural areas.

Previously Japanese doctors were only allowed to treat recurring patients remotely, and for a limited number of diseases.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

The rapid pace of change caught executives at Line Corp. off guard, forcing Japan’s most popular social networking service to accelerate plans for the rollout of its Line Healthcare business in the coming months.

“The effect that COVID-19 brought was a huge innovation in the healthcare industry,” says Shinichiro Muroyama, representative director of Line Healthcare. “The situation has totally changed, much more rapidly than we thought.”

Line, which says it has 84 million users in Japan, aims to link doctors and patients by video.

Homegrown medical start-ups, such as Medley Inc. and MICIN Inc., say they have also seen a surge in demand. Both companies offer application services for appointments, video consultations and payments.

Telehealth or telemedicine refers to technology that includes online consultations, cloud-based medical records, remote monitoring of patients and use of artificial intelligence to screen for diseases.

Japan’s market for such technology is set to grow by 60% to nearly 20 billion yen ($185 million; $1 = 107.5200 yen) in the five years to March 2024, according to the Yano Research Institute.

Japanese Prime Minister Shinzo Abe has made deregulating the medical industry part of his growth strategy.

Better Outcomes
So Ishii, a doctor who runs a clinic in Tokyo that started offering telemedicine in 2017, has seen a jump in online consultations since the outbreak, with 600 patients using the service as of mid-June compared to 400 two months earlier.

Dr. Ishii says telehealth could lead to better treatment for patients with lifestyle-related diseases that require continuous attention because it gave them easier access to doctors. Such ailments typically include diabetes and high-blood pressure.

“Ideally, medical care should be designed to provide necessary support for patients regardless of whether it is online or on site,” he says.

About 16,100 Japanese medical institutions excluding dentists—nearly 15% of all such facilities—offered remote medical services, including by telephone, as of early July, according to the health ministry.

That marks substantial growth since July 2018, when only 970 medical institutions were registered to offer online care.

Still, the health ministry has not decided whether to make the changes permanent, while the national medical association is less than enthusiastic, citing concerns about misdiagnosis.

“We should be extremely cautious about using evidence drawn from telemedicine in the emergency situation for consideration of how it should be after the coronavirus infection wanes,” Japan Medical Association President Toshio Nakagawa tells Reuters. He was vice-president at the time of the interview.

Analysts say telemedicine can also put smaller clinics at a financial disadvantage.

Goichiro Toyoda, representative director and a medical doctor at Medley, agrees doctors can better check first-time patients in person but says telemedicine suits patients who want second opinions, have trouble visiting hospitals or need long-term treatments.

“Telemedicine will not replace face-to-face treatment,” says Dr. Toyoda. “But I’ve been stressing the importance of it becoming an option.”

Page: 1 2 | Multi-Page
Share: 

Filed under:Technology Tagged with:InternationalJapanpatient careTechnologytelemedicine

Related Articles

    The Doctor Will See You Now: Legal & Regulatory Reforms Expand Telemedicine

    March 17, 2020

    In this time of COVID-19, you may be considering ways to deliver routine rheumatologic care via some form of telemedicine. Here are some of the legal considerations.

    Practicing Telemedicine Raises Legal Considerations for Rheumatologists

    July 12, 2016

    m.jrn/shutterstock.com With the evolution and advancement of technology, it was only a matter of time before such changes affected the medical industry. Although the concept of telemedicine dates back more than 50 years, emphasis on cost-effective quality healthcare coupled with technological advancements has caused a resurgence of telemedicine in recent years. What constitutes telemedicine largely…

    Outpatient Medicine in the Post-COVID-19 Era of Telemedicine

    October 19, 2020

    anttoniart / shutterstock.com Our hospitals have had their finest hour in the care of acutely ill inpatients during the COVID-19 pandemic, including dealing with allocation decisions fairly and transparently, maximizing good outcomes and remaining cognizant of the enduring ethics of healthcare. The honorable traditions of self-effacing conduct and acceptance of some level of personal risk…

    Some Telemedicine Barriers Are Down During COVID-19 Pandemic

    May 15, 2020

    Agenturfotografin / shutterstock.com Telerheumatology—which refers to the application of electronic communication technology to clinical encounters from a distance between rheumatologists and their patients—has the potential to extend a workforce projected to experience significant shortfalls, making it more accessible to more patients. Multiple barriers that stood in the way of taking full advantage of this promise…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences